Antiglycosphingolipid Immune Responses in Neurology: The Vienna Experience with Isotypes, Subclasses, and Diseasea
- 1 June 1998
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 845 (1) , 353-362
- https://doi.org/10.1111/j.1749-6632.1998.tb09687.x
Abstract
IgM, IgG, IgA, and IgG subclass anti‐GM1, anti‐GQ1b, and anti‐asialo‐GM1 (anti‐GA1) antibodies, respectively, were investigated by ELISA in serum from neurological and other patients. Increased anti‐GM1 occurred mostly in ∼35–15% of the cases without statistical differences; high percentages were found in Guillain‐Barré syndrome (GBS) preceded by gastrointestinal infection and multifocal motor neuropathy. Roughly, IgM anti‐GM1 was most frequent; however, distinct IgG and IgA reactions were found i.a. in GBS. A particular IgM anti‐mono‐ and disialoganglioside pattern occurred in a patient with sensorimotor neuropathy and paraproteinemia. Anti‐GQ1b was elevated in all Miller‐Fisher patients, with some prevalence of IgG2 among IgG subclasses. Cross‐reactivity of anti‐GQ1b was demonstrated with Campylobacter jejuni lipopolysaccharides. Increased anti‐GM1 and/or anti‐GA1 was more frequent in systemic lupus erythematosus with central nervous system involvement than without. Incidence of anti‐GM1 and anti‐GA1 in X‐adrenoleukodystrophy was relatively high.Although anti‐GSL antibodies seem to have limited diagnostic value, studies of isotypes, subclass patterns, and cross‐reactivities may lead to further insight into the origin of (auto)immune responses and their immunepathogenetic role in disease.Keywords
This publication has 25 references indexed in Scilit:
- Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndromeInnate Immunity, 1995
- Presence and isotype of anti-ganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous systemJournal of Neuroimmunology, 1995
- Chronic progressive motor polyneuropathy after ganglioside treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Gangliosides and bacterial toxins in Guillain-Barré syndromeJournal of Neuroimmunology, 1993
- Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharideEuropean Journal of Biochemistry, 1993
- Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharidesEuropean Journal of Biochemistry, 1993
- Invited review: Motor neuropathies, motor neuron disorders, and antiglycolipid antibodiesMuscle & Nerve, 1991
- Neuropsychiatric manifestations of systemic lupus erythematosus: The value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodiesClinical Rheumatology, 1990
- Measurement and significance of antibodies against GM1 ganglioside Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.Journal of Neuroimmunology, 1989
- Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophyAnnals of Neurology, 1985